Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902303 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
A Phase 2 study of Oral Herpes Simplex, sponsored by Beech Tree Labs.
- Completed
- Registry status
- Phase 2
- Development phase
- 303
- Enrollment target
- 3
- Study locations
NCT01902303 is a Phase 2 study of Oral Herpes Simplex that has completed, run by Beech Tree Labs. The registered enrollment target is 303 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT01902303, a Phase 2 study of Oral Herpes Simplex, has completed, sponsored by Beech Tree Labs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 303 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine if a new drug treatment is effective to block the development of a cold sore lesion following Ultra Violet (UV) exposure.
Conditions Studied
Interventions
- DRUG Matching Placebo
- DRUG BTL-TML-HSV
Study Locations (3)
Florida
- Hill Top Research - St. Petersburg
Ohio
- Hill Top Research - Cincinnati
South Carolina
- Coastal Carolina Research Center - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01902303
The ClinicalTrials.gov registry entry for NCT01902303 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beech Tree Labs, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oral Herpes Simplex appearing as the primary indexed condition, and to 2 interventions - of which Matching Placebo is the first listed.
NCT01902303 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Ohio, South Carolina.
Frequently Asked Questions
What is clinical trial NCT01902303 about?
NCT01902303 is a clinical study titled "Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores". The purpose of this study is to determine if a new drug treatment is effective to block the development of a cold sore lesion following Ultra Violet (UV) exposure.
What is the current status of trial NCT01902303?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 303 participants. The study started on 2013-07. Estimated completion is 2015-02.
What conditions does trial NCT01902303 study?
This clinical trial studies the following conditions: Oral Herpes Simplex.
What interventions are being tested in trial NCT01902303?
The interventions under investigation include: Matching Placebo (DRUG), BTL-TML-HSV (DRUG).
Who is sponsoring clinical trial NCT01902303?
This trial is sponsored by Beech Tree Labs, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01902303 being conducted?
This trial has 3 study locations across Florida, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.